ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
You Can See More: Zantac cancer risk: Heartburn drug suspended by CVS Pharmacy after cancer fears
The following article Zantac cancer risk: Heartburn drug suspended by CVS Pharmacy after cancer fears is courtesy of Daily Express :: Health Feed
ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.